RUI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 774
EU - Europa 513
AS - Asia 418
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.709
Nazione #
US - Stati Uniti d'America 766
CN - Cina 358
IE - Irlanda 240
DE - Germania 75
IT - Italia 69
FI - Finlandia 46
IN - India 33
FR - Francia 30
UA - Ucraina 24
SG - Singapore 16
GB - Regno Unito 12
BE - Belgio 6
CA - Canada 5
JP - Giappone 4
AT - Austria 3
RU - Federazione Russa 3
CU - Cuba 2
HK - Hong Kong 2
LT - Lituania 2
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IL - Israele 1
MU - Mauritius 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.709
Città #
Dublin 240
Chandler 214
Nanjing 83
Beijing 70
Ashburn 58
New York 44
Jacksonville 43
Boardman 39
Pavia 36
Princeton 36
Shanghai 35
Lawrence 34
Nanchang 30
Changsha 28
Helsinki 28
Wilmington 28
Hebei 26
Medford 23
Munich 23
Pune 23
Shenyang 20
Jiaxing 19
Piscataway 17
Tianjin 16
Ann Arbor 15
Hangzhou 15
Los Angeles 10
Singapore 9
Couilly-pont-aux-dames 8
Milan 8
Brussels 6
Dallas 6
Fairfield 6
Weston-super-Mare 6
Kishangarh 5
Woodbridge 5
Aachen 4
Cagliari 4
Norwalk 4
Trezzano Rosa 4
Guangzhou 3
Moscow 3
Orange 3
Redwood City 3
Tokyo 3
Toronto 3
Vienna 3
Zhengzhou 3
Chicago 2
Cittadella 2
Falkenstein 2
Havana 2
Jinan 2
Long Beach 2
Nagold 2
Albuquerque 1
Andover 1
Berlin 1
Brno 1
Böblingen 1
Central 1
Chongqing 1
Delhi 1
Dhaka 1
Esslingen am Neckar 1
Johannesburg 1
Kampong Loyang 1
London 1
Napoli 1
Ningbo 1
Paris 1
Phoenix 1
Seattle 1
Taichung 1
Torino 1
Valdagno di Trento 1
Verrua Po 1
Washington 1
Winnipeg 1
Totale 1.390
Nome #
New perspectives in cancer therapy: the biotin-antitumor molecule conjugates 83
Marrubium vulgare l. leave extract: Phytochemical composition, antioxidant and wound healing properties 76
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 73
Approaches for multi-gram scale isolation of enantiomers for drug discovery 72
Gaining in Pan-Affinity Towards Sigma 1 and Sigma 2 Receptors. SAR studies on arylalkylamines 71
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 70
Towards sigma1 receptor agonists as neuroprotective agents. Preparation, configurational assignment and in vitro biological profile 65
TOWARDS THE DISCOVERY OF NOVEL SIGMA RECEPTOR MODULATORS: ORGANOLITHIUM-METHODS BASED SYNTHESIS AND BIOLOGICAL EVALUATIONS 65
Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). 57
New Perspectives in Lithium Carbenoid Mediated Homologations 57
Alginate-based electrospun fibers for the delivery of sigma-1 receptor agonists in the treatment of spinal cord injuries 57
Electrospun alginate-PEO fibers for the delivery of sigma-1 receptor agonists in the treatment of SCI: influence of PEO molecular weight on fiber production. 57
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 56
PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106 55
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. 53
Regulation of aquaporin functional properties mediated by the antioxidant effects of natural compounds 51
“Fit-for-purpose” development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel sigma1 receptor agonist. 51
Comparison of chitosan oleate preparation methods and emulsion stabilization 51
Are sigma receptor modulators a weapon against multiple sclerosis disease? 51
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents 49
Sigma Receptors: Novel Targets For The Treatment Of Highly Malignant Tumors 48
Sigma receptors as endoplasmic reticulum stress "gatekeepers" and their modulators as emerging new weapons in the fight against cancer 48
On the study of stereoselectivity in the ligand - Sigma1 receptor interaction. 46
Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent. 46
New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative 44
PEG 400/cerium ammonium nitrate combined with microwave-assisted synthesis for rapid access to beta-amino ketones. an easy-to-use protocol for discovering new hit compounds 43
Novel enantiopure sigma receptor modulators: Quick (semi-)preparative chiral resolution via hplc and absolute configuration assignment 43
PKC in regenerative therapy: New insights for old targets 42
CHAPTER 12: Sigma Receptors as New Target for Multiple Sclerosis 41
Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films 40
Some natural compounds exert their antioxidant effect by altering aquaporins functional properties 31
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R) 31
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 30
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead 27
Cross-linked alginate-based nanofibrous membrane in chitosan film to improve neural tissue regeneration. 22
Totale 1.802
Categoria #
all - tutte 7.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 3 2 3 1 11 8 30 39 0
2020/202192 7 6 0 7 0 19 2 23 8 15 4 1
2021/2022166 4 1 1 0 1 1 2 9 9 4 22 112
2022/2023614 62 57 9 35 46 63 0 27 275 7 14 19
2023/2024321 32 44 3 10 20 97 35 21 3 14 35 7
2024/2025107 10 59 35 3 0 0 0 0 0 0 0 0
Totale 1.802